RNCOS Releases Report on Global Protein Therapeutics Market Analysis
Delhi, India, January 24, 2008 --(PR.com)-- The leading market research company RNCOS has added a new report, “Global Protein Therapeutics Market Analysis”, in its Healthcare category of reports. This report is an exhaustive view on the global protein therapeutics industry, examining and giving a detailed analysis of various protein therapeutics used for disease prevention. It discusses various aspects of the protein therapeutic market, such as market size, area of applications and key geographical markets along with the drivers and restraints affecting the growth of each segment.
Market Analysis
The Protein Therapeutic Market was valued in excess of US$ 57 Billion in 2006 and according to projections, it would grow at a CAGR 12.83% till 2010. The market is presently dominated by Monoclonal Antibodies and with double-digit growth projected for future, the segment is expected to bolster its dominant position. Insulin, Interferon Beta, G-CSF and coagulation factors are also exhibiting double-digit growth rates.
One of the biggest opportunity areas in the protein therapeutics market will be in the field of Biogenerics, which is expected to create a multi-billion dollar market in future.
Key Issues and Facts Analyzed
- Evaluation of past, current and future market trends.
- Discussion about the major protein therapeutics and their markets.
- Analysis of key geographical markets.
- Analysis of various challenges and opportunities for the industry.
- Future prospects of the various protein therapeutics segments.
- Profile discussion of key players in this sector.
Key Players Analyzed
This section provides the overview, key facts, and financial information of prominent players in the global protein therapeutics market, such as Amgen, Genentech, Roche Group, Merck Serono S.A, Johnson & Johnson, Novo Nordisk A/S etc.
Research Methodology Used
Information Sources
Information has been sourced from credible sources including books, newspapers, trade journals, and white papers, industry portals, government agencies, trade associations, monitoring industry news and developments, and through access to more than 3000 paid databases.
Analysis Methods
The analysis methods include ratio analysis, historical trend analysis, linear regression analysis using software tools, judgmental forecasting, and cause and effect analysis.
For the purpose of this report, the following segments have been included in the Protein Therapeutics Market:
Monoclonal antibodies, EPO, Interferon’s, Blood Clotting Factors, HGH, FSH, G-CSF and Insulin
The following currency conversion has been followed in the report:
1 US$ = Euros 0.73, JPY 121
About RNCOS:
RNCOS, incorporated in the year 2002, is an industry research firm. It has a team of industry experts who analyze data collected from credible sources. They provide industry insights and analysis that helps corporations to take timely and accurate business decision in today's globally competitive environment.
For more information visit: http://www.rncos.com/Report/IM557.htm
Current Industry News: http://www.rncos.com/Blog/
###
Market Analysis
The Protein Therapeutic Market was valued in excess of US$ 57 Billion in 2006 and according to projections, it would grow at a CAGR 12.83% till 2010. The market is presently dominated by Monoclonal Antibodies and with double-digit growth projected for future, the segment is expected to bolster its dominant position. Insulin, Interferon Beta, G-CSF and coagulation factors are also exhibiting double-digit growth rates.
One of the biggest opportunity areas in the protein therapeutics market will be in the field of Biogenerics, which is expected to create a multi-billion dollar market in future.
Key Issues and Facts Analyzed
- Evaluation of past, current and future market trends.
- Discussion about the major protein therapeutics and their markets.
- Analysis of key geographical markets.
- Analysis of various challenges and opportunities for the industry.
- Future prospects of the various protein therapeutics segments.
- Profile discussion of key players in this sector.
Key Players Analyzed
This section provides the overview, key facts, and financial information of prominent players in the global protein therapeutics market, such as Amgen, Genentech, Roche Group, Merck Serono S.A, Johnson & Johnson, Novo Nordisk A/S etc.
Research Methodology Used
Information Sources
Information has been sourced from credible sources including books, newspapers, trade journals, and white papers, industry portals, government agencies, trade associations, monitoring industry news and developments, and through access to more than 3000 paid databases.
Analysis Methods
The analysis methods include ratio analysis, historical trend analysis, linear regression analysis using software tools, judgmental forecasting, and cause and effect analysis.
For the purpose of this report, the following segments have been included in the Protein Therapeutics Market:
Monoclonal antibodies, EPO, Interferon’s, Blood Clotting Factors, HGH, FSH, G-CSF and Insulin
The following currency conversion has been followed in the report:
1 US$ = Euros 0.73, JPY 121
About RNCOS:
RNCOS, incorporated in the year 2002, is an industry research firm. It has a team of industry experts who analyze data collected from credible sources. They provide industry insights and analysis that helps corporations to take timely and accurate business decision in today's globally competitive environment.
For more information visit: http://www.rncos.com/Report/IM557.htm
Current Industry News: http://www.rncos.com/Blog/
###
Contact
RNCOS
Shushmul Maheshwari
91-11-4214-1229
www.rncos.com
Head of Business Development
29, 1st Floor, Patparganj Industrial Area, Delhi 92
Shushmul Maheshwari
91-11-4214-1229
www.rncos.com
Head of Business Development
29, 1st Floor, Patparganj Industrial Area, Delhi 92
Contact
Categories